# A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants

> **NCT06533475** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 18 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Minzasolmin tablet formulation under fasting condition
- **DRUG:** Minzasolmin Granules in capsule under fasting condition
- **DRUG:** Minzasolmin tablet formulation under fed condition

## Key facts

- **NCT ID:** NCT06533475
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-06
- **Primary completion:** 2024-11-17
- **Final completion:** 2024-11-17
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06533475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06533475, "A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06533475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*